Using UNC's expertise to fight emerging diseases

Posted Jul 13, 2018
Gilead Sciences, Inc., and Carolina are teaming up to save lives. The biopharmaceutical company sought the University's resources and talents in the development of treatments to control disease outbreaks. Imagine: One drug with the potential to treat MERS, SARS, Ebola, and the common cold. At Carolina, researchers are imagining — and enabling — just that. (UNC.edu)

Related: Campus Connections

Your Guide to Chapel Hill
Carolina blue adorns almost every corner of Chapel Hill — even fire trucks sport the sky-blue shade. Soon, you’ll understand the appeal: Wander through the...
Tue Apr 30, 2024

Chapel Hill recently awarded grants to help 3 businesses stay downtown
In January, the Town of Chapel Hill announced that it made grants to three business - Cosmic Cantina, Purple Bowl, and Wade’s Hair Studio &...
Mon Apr 29, 2024

Late night on Franklin Street: A guide to finding your next midnight snack
A landmark of Chapel Hill and Franklin Street, Time-Out has been serving comfort Southern food since 1978 and still is all day, every day. According...
Sat Apr 27, 2024

UNC Hospitals Named One of World’s Best Hospitals in 2024
UNC Hospitals in Chapel Hill earned a spot on Newsweek’s “World’s Best Hospitals 2024” list. It’s one of three UNC Health institutions named to the...
Fri Apr 26, 2024